NASDAQ:APDN

Applied DNA Sciences - APDN Stock Forecast, Price & News

$1.13

-0.09 (-7.38%)

(As of 09/30/2022 12:00 AM ET)

Add

Compare

Today's Range: $1.12
▼
$1.35
50-Day Range: $0.68
▼
$5.83
52-Week Range: $0.62
▼
$7.35

Volume: 347,930 shs
Average Volume: 2.61 million shs
Market Capitalization: $13.54 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $7.00

Applied DNA Sciences MarketRank™ Forecast

Analyst Rating: N/A
0.00 Rating Score
Upside/Downside: 519.5% Upside
$7.00 Price Target
Short Interest: Healthy
6.64% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.86
Based on 7 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($1.43) to ($0.83) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.69 out of 5 stars

Industrial Products Sector

171st out of 187 stocks

Miscellaneous Business Services Industry

6th out of 6 stocks

2.0

Analyst's Opinion

Price Target Upside/Downside
According to analysts' consensus price target of $7.00, Applied DNA Sciences has a forecasted upside of 519.5% from its current price of $1.13.
Amount of Analyst Coverage
Applied DNA Sciences has received no research coverage in the past 90 days.

4.0

Short Interest

Percentage of Shares Shorted
6.64% of the outstanding shares of Applied DNA Sciences have been sold short.
Short Interest Ratio / Days to Cover
Applied DNA Sciences has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Applied DNA Sciences has recently decreased by 15.11%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Applied DNA Sciences does not currently pay a dividend.
Dividend Growth
Applied DNA Sciences does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for APDN.

2.7

News and Social Media Coverage

News Sentiment
Applied DNA Sciences has a news sentiment score of 0.86. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Industrial Products companies.
News Coverage This Week
MarketBeat has tracked 7 news articles for Applied DNA Sciences this week, compared to 2 articles on an average week.
Search Interest
Only 4 people have searched for APDN on MarketBeat in the last 30 days. This is a decrease of -95% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added Applied DNA Sciences to their MarketBeat watchlist in the last 30 days. This is a decrease of -96% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Applied DNA Sciences insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 6.37% of the stock of Applied DNA Sciences is held by insiders.
Percentage Held by Institutions
Only 10.34% of the stock of Applied DNA Sciences is held by institutions.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Applied DNA Sciences are expected to grow in the coming year, from ($1.43) to ($0.83) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Applied DNA Sciences is -0.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Applied DNA Sciences is -0.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Applied DNA Sciences has a P/B Ratio of 0.76. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Applied DNA Sciences (NASDAQ:APDN) Stock

Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide real-time authentication of molecular tags in the field; and CertainT, which indicates the use of tagging, testing, and tracking platforms and solutions enabling manufacturers, brands, and trade organizations to convey proof of their product claims. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and COVID-19 diagnostic test kit to prevent virus spread within a community, school, or workplace under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. Further, it develops an invasive circulating tumor cell capture and identification technology that uses a patented functional assay to capture live invasive circulating tumor cell and associated lymphocytes. The company operates in the United States, Europe, Asia, and internationally. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.

Receive APDN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter.

APDN Stock News Headlines

September 30, 2022 | finance.yahoo.com

Applied DNA’s Biotherapeutics Subsidiary Publishes Manuscript Demonstrating that a LinearDNA™ Vaccine Candidate was Protective in Virus Challenge Trial in Ferrets

September 28, 2022 | seekingalpha.com

APDN Applied DNA Sciences, Inc.

September 26, 2022 | americanbankingnews.com

Applied DNA Sciences (NASDAQ:APDN) Upgraded to Hold by StockNews.com

September 24, 2022 | finance.yahoo.com

Applied DNA Sciences, Inc. (APDN)

September 8, 2022 | finance.yahoo.com

Applied DNA and the Cornell University College of Veterinary Medicine Announce Research Collaboration to Accelerate Application of LinearDNA™ Platform for Veterinary Health Applications

September 7, 2022 | finance.yahoo.com

Applied DNA to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022

September 6, 2022 | finance.yahoo.com

Applied DNA Launches Monkeypox Testing Service

August 19, 2022 | finance.yahoo.com

Applied DNA Submits PCR-based Monkeypox Virus Diagnostic Test for Approval to New York State Department of Health

August 17, 2022 | finance.yahoo.com

Analyst Forecasts For Applied DNA Sciences, Inc. (NASDAQ:APDN) Are Surging Higher

August 12, 2022 | seekingalpha.com

Applied DNA Sciences stock falls ~14% after massive runup last week, Q3 results

August 11, 2022 | finance.yahoo.com

Applied DNA Reports Third Quarter Fiscal 2022 Financial Results

August 11, 2022 | finance.yahoo.com

Applied DNA Sciences (APDN) Reports Q3 Loss, Tops Revenue Estimates

August 10, 2022 | finance.yahoo.com

Applied DNA Biotherapeutics Subsidiary Reports LinearDNA™ Platform Development Milestone: First Successful Administration of LinearDNA In Vivo via Lipid Nanoparticles (LNP)

August 9, 2022 | finance.yahoo.com

Applied DNA Receives Approximately $3.6 Million in Net Proceeds from Warrant Exercise

August 9, 2022 | finance.yahoo.com

Applied DNA Awarded Extension of Health Services Contract with The City University of New York

August 8, 2022 | finance.yahoo.com

Applied DNA Announces Closing of Upsized $12 Million Public Offering

August 8, 2022 | finance.yahoo.com

Applied DNA to Host Conference Call and Webcast Discussing Fiscal 2022 Third Quarter Results and Corporate Updates

August 5, 2022 | nasdaq.com

Is Applied DNA Sciences (NASDAQ:APDN) In A Good Position To Invest In Growth?

August 3, 2022 | msn.com

Short Volatility Alert: Applied DNA Sciences, Inc.

August 3, 2022 | benzinga.com

Looking At Applied DNA Sciences's Recent Whale Trades

August 3, 2022 | finance.yahoo.com

Will Applied DNA Sciences (NASDAQ:APDN) Spend Its Cash Wisely?

August 3, 2022 | finance.yahoo.com

Applied DNA stock soars more than 80% active trading, after quadrupling in the previous session

August 2, 2022 | finance.yahoo.com

Applied DNA Sciences Shares Triples After Monkeypox Diagnostic Test Update

August 2, 2022 | finance.yahoo.com

Applied DNA Initiates Analytical Validation of PCR-based Diagnostic Test Specific to Monkeypox Virus

July 25, 2022 | finance.yahoo.com

Applied DNA Biotherapeutics Subsidiary LineaRx and EvviVax Publish Additional Positive Animal Proof-of-Concept Data Supporting LinearDNA™ Platform as a Unique Approach to Veterinary DNA Vaccine Development

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive APDN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter.

APDN Company Calendar

Last Earnings: 8/11/2022
Today: 10/01/2022
Next Earnings (Estimated): 12/08/2022
Fiscal Year End: 9/30/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Miscellaneous business services
Sub-Industry: N/A
Sector: Industrial Products
Current Symbol: NASDAQ:APDN
CUSIP: N/A
CIK: 744452
Web: www.adnas.com
Phone: (631) 240-8800
Fax: 631-240-8900
Employees: 78
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $7.00
High Stock Price Forecast: $8.00
Low Stock Price Forecast: $6.00
Forecasted Upside/Downside: +519.5%
Consensus Rating: N/A
Rating Score (0-4): 0.00
Research Coverage: 0 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.59)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-14,290,000.00
Net Margins: -68.79%
Pretax Margin: -68.79%
Return on Equity: -158.37%
Return on Assets: -104.15%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 2.16
Quick Ratio: 1.89

Sales & Book Value

Annual Sales: $9.03 million
Price / Sales: 1.50
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.48 per share
Price / Book: 0.76

Miscellaneous

Outstanding Shares: 11,983,000
Free Float: 11,220,000
Market Cap: $13.54 million
Optionable: Optionable
Beta: 0.07

Key Executives

Dr. James A. Hayward Ph.D. (Age 68)
Sc.D., Chairman, Pres & CEO
Comp: $984.84k

Ms. Beth M. Jantzen CPA (Age 46)
CPA, Chief Financial Officer
Comp: $278.85k

Ms. Judith Murrah (Age 64)
COO & Sec.
Comp: $314.42k

Mr. Sanjay M. Hurry
Exec. Director of Investor Relations & Corp. Communications

Mr. Clay Shorrock Esq. (Age 37)
J.D., Chief Legal Officer & Exec. Director of Bus. Devel.

Mr. John Shearman
Exec. Director of Marketing & Cannabis Bus.

Mr. Tony Benson
Managing Director of EMEA

Ms. Janice Meraglia
VP, Gov. & Military Programs

Ms. MeiLin Wan
VP of Textile Sales

Dr. Stephen Hughes
Director of DNA Programs

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

APDN Stock - Frequently Asked Questions

What is Applied DNA Sciences' stock price forecast for 2022?: 0 Wall Street research analysts have issued twelve-month price targets for Applied DNA Sciences' stock. Their APDN share price forecasts range from $6.00 to $8.00. On average, they expect the company's stock price to reach $7.00 in the next twelve months. This suggests a possible upside of 519.5% from the stock's current price.
View analysts price targets for APDN or view top-rated stocks among Wall Street analysts.
How have APDN shares performed in 2022?: Applied DNA Sciences' stock was trading at $4.02 at the beginning of the year. Since then, APDN stock has decreased by 71.9% and is now trading at $1.13.
View the best growth stocks for 2022 here.
When is Applied DNA Sciences' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, December 8th 2022.
View our APDN earnings forecast.
How were Applied DNA Sciences' earnings last quarter?: Applied DNA Sciences, Inc. (NASDAQ:APDN) issued its earnings results on Thursday, August, 11th. The technology company reported ($0.13) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.32) by $0.19. Applied DNA Sciences had a negative trailing twelve-month return on equity of 158.37% and a negative net margin of 68.79%.

What is James A. Hayward's approval rating as Applied DNA Sciences' CEO?: 2 employees have rated Applied DNA Sciences Chief Executive Officer James A. Hayward on Glassdoor.com. James A. Hayward has an approval rating of 100% among the company's employees. This puts James A. Hayward in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 100.0% of employees surveyed would recommend working at Applied DNA Sciences to a friend.
What other stocks do shareholders of Applied DNA Sciences own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Applied DNA Sciences investors own include Inovio Pharmaceuticals (INO), Advanced Micro Devices (AMD), Ekso Bionics (EKSO), Micron Technology (MU), Arbutus Biopharma (ABUS), VBI Vaccines (VBIV), Gilead Sciences (GILD), Vaxart (VXRT), Sorrento Therapeutics (SRNE) and Intel (INTC).
What is Applied DNA Sciences' stock symbol?: Applied DNA Sciences trades on the NASDAQ under the ticker symbol "APDN."
How do I buy shares of Applied DNA Sciences?: Shares of APDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Applied DNA Sciences' stock price today?: One share of APDN stock can currently be purchased for approximately $1.13.
How much money does Applied DNA Sciences make?: Applied DNA Sciences (NASDAQ:APDN) has a market capitalization of $13.54 million and generates $9.03 million in revenue each year. The technology company earns $-14,290,000.00 in net income (profit) each year or ($1.59) on an earnings per share basis.
How can I contact Applied DNA Sciences?: Applied DNA Sciences' mailing address is 50 HEALTH SCIENCES DRIVE, STONY BROOK NY, 11790. The official website for the company is www.adnas.com. The technology company can be reached via phone at (631) 240-8800, via email at investor@adnas.com, or via fax at 631-240-8900.

This page (NASDAQ:APDN) was last updated on 10/1/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Applied DNA Sciences - APDN Stock Forecast, Price & News

Applied DNA Sciences MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows